M G Kent-First|S Kol|A Muallem|S Blazer|J Itskovitz-Eldor - JoVE Visualize

Showing results (1-10 of 261) with videos related to

Pageof 27

Sort By:

Molecular Human Reproduction|December 1, 1996

The incidence and possible relevance of Y-linked microdeletions in babies born after intracytoplasmic sperm injection and their infertile fathersM G Kent-First, S Kol, A Muallem, et al.

Human Reproduction (Oxford, England)|November 1, 2000

Severe OHSS: yes, there is a strategy to prevent it!S Kol, J Itskovitz-Eldor

Clinical Obstetrics and Gynecology|September 1, 1993

Use of gonadotropin-releasing hormone agonist to cause ovulation and prevent the ovarian hyperstimulation syndromeJ Itskovitz-Eldor, J Levron, S Kol

Human Reproduction (Oxford, England)|September 1, 2000

Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communicationJ Itskovitz-Eldor, S Kol, B Mannaerts

Human Reproduction (Oxford, England)|October 21, 1999

A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cyclesA Lightman, S Kol, J Itskovitz-Eldor

Fertility and Sterility|July 19, 2000

Ovarian stimulation in in vitro fertilization with or without the "long" gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcomeR Beloosesky, S Kol, A Lightman, et al.

Fertility and Sterility|October 1, 1996

does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome?N Lewit, S Kol, N Ronen, et al.

Human Reproduction (Oxford, England)|July 1, 1996

Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control studyN Lewit, S Kol, D Manor, et al.

Human Reproduction (Oxford, England)|April 29, 1998

First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462)J Itskovitz-Eldor, S Kol, B Mannaerts, et al.

The Journal of Clinical Endocrinology and Metabolism|February 1, 1997

Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndromeJ Itskovitz-Eldor, S Kol, N Lewit, et al.

Pageof 27

Showing results (1-10 of 261) with videos related to

Sort By:

Pageof 27

Molecular Human Reproduction|December 1, 1996

The incidence and possible relevance of Y-linked microdeletions in babies born after intracytoplasmic sperm injection and their infertile fathersM G Kent-First, S Kol, A Muallem, et al.

Human Reproduction (Oxford, England)|November 1, 2000

Severe OHSS: yes, there is a strategy to prevent it!S Kol, J Itskovitz-Eldor

Clinical Obstetrics and Gynecology|September 1, 1993

Use of gonadotropin-releasing hormone agonist to cause ovulation and prevent the ovarian hyperstimulation syndromeJ Itskovitz-Eldor, J Levron, S Kol

Human Reproduction (Oxford, England)|September 1, 2000

Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communicationJ Itskovitz-Eldor, S Kol, B Mannaerts

Human Reproduction (Oxford, England)|October 21, 1999

A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cyclesA Lightman, S Kol, J Itskovitz-Eldor

Fertility and Sterility|July 19, 2000

Ovarian stimulation in in vitro fertilization with or without the "long" gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcomeR Beloosesky, S Kol, A Lightman, et al.

Fertility and Sterility|October 1, 1996

does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome?N Lewit, S Kol, N Ronen, et al.

Human Reproduction (Oxford, England)|July 1, 1996

Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control studyN Lewit, S Kol, D Manor, et al.

Human Reproduction (Oxford, England)|April 29, 1998

First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462)J Itskovitz-Eldor, S Kol, B Mannaerts, et al.

The Journal of Clinical Endocrinology and Metabolism|February 1, 1997

Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndromeJ Itskovitz-Eldor, S Kol, N Lewit, et al.

Pageof 27